| Tigecycline: first of a new class of antimicrobial agents WE Rose, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (8 …, 2006 | 228 | 2006 |
| Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms LS Miller, VG Fowler Jr, SK Shukla, WE Rose, RA Proctor FEMS microbiology reviews 44 (1), 123-153, 2020 | 196 | 2020 |
| Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline G Sakoulas, PA Moise, AM Casapao, P Nonejuie, J Olson, CYM Okumura, ... Clinical therapeutics 36 (10), 1317-1333, 2014 | 193 | 2014 |
| Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus WE Rose, PT Poppens Journal of Antimicrobial Chemotherapy 63 (3), 485-488, 2009 | 178 | 2009 |
| Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm J Parra-Ruiz, C Vidaillac, WE Rose, MJ Rybak Antimicrobial agents and chemotherapy 54 (10), 4329-4334, 2010 | 169 | 2010 |
| Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia M Geriak, F Haddad, K Rizvi, W Rose, R Kullar, K LaPlante, M Yu, ... Antimicrobial agents and chemotherapy 63 (5), 10.1128/aac. 02483-18, 2019 | 151 | 2019 |
| Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles J Slane, J Vivanco, W Rose, HL Ploeg, M Squire Materials Science and Engineering: C 48, 188-196, 2015 | 150 | 2015 |
| Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a … BJ Werth, G Sakoulas, WE Rose, J Pogliano, R Tewhey, MJ Rybak Antimicrobial agents and chemotherapy 57 (1), 66-73, 2013 | 147 | 2013 |
| Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity WE Rose, LT Schulz, D Andes, R Striker, AD Berti, PR Hutson, SK Shukla Antimicrobial agents and chemotherapy 56 (10), 5296-5302, 2012 | 129 | 2012 |
| The role of antibiotics in modulating virulence in Staphylococcus aureus E Hodille, W Rose, BA Diep, S Goutelle, G Lina, O Dumitrescu Clinical microbiology reviews 30 (4), 887-917, 2017 | 123 | 2017 |
| Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes SL Davis, PS McKinnon, LM Hall, G Delgado Jr, W Rose, RF Wilson, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (12 …, 2007 | 116 | 2007 |
| Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia WE Rose, JC Eickhoff, SK Shukla, M Pantrangi, S Rooijakkers, ... The Journal of infectious diseases 206 (10), 1604-1611, 2012 | 114 | 2012 |
| Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities … WE Rose, SN Leonard, MJ Rybak Antimicrobial agents and chemotherapy 52 (9), 3061-3067, 2008 | 106 | 2008 |
| The “epic” challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology R Kullar, DA Goff, LT Schulz, BC Fox, WE Rose Clinical infectious diseases 57 (7), 1005-1013, 2013 | 103 | 2013 |
| Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations WE Rose, SN Leonard, G Sakoulas, GW Kaatz, MJ Zervos, A Sheth, ... Antimicrobial agents and chemotherapy 52 (3), 831-836, 2008 | 102 | 2008 |
| Poly (amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity SJ Strydom, WE Rose, DP Otto, W Liebenberg, MM De Villiers Nanomedicine: nanotechnology, biology and medicine 9 (1), 85-93, 2013 | 101 | 2013 |
| Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium G Sakoulas, W Rose, P Nonejuie, J Olson, J Pogliano, R Humphries, ... Antimicrobial agents and chemotherapy 58 (3), 1494-1500, 2014 | 100 | 2014 |
| Structure and biosynthesis of the antibiotic bottromycin D Y Hou, MDB Tianero, JC Kwan, TP Wyche, CR Michel, GA Ellis, ... Organic letters 14 (19), 5050-5053, 2012 | 96 | 2012 |
| Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies WE Rose, MJ Rybak, GW Kaatz Journal of antimicrobial chemotherapy 60 (2), 334-340, 2007 | 90 | 2007 |
| β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus AD Berti, G Sakoulas, V Nizet, R Tewhey, WE Rose Antimicrobial agents and chemotherapy 57 (10), 5005-5012, 2013 | 88 | 2013 |
Michael J. Rybak, Pharm.D., M.P.H., P...Wayne State UniversityBestätigte E-Mail-Adresse bei wayne.edu
